Cellectis CLLS
NASDAQ CLLS
$3.24 -0.08 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Cellectis (CLLS) Interest Expenses (2021 - 2026)

Cellectis (CLLS) posted quarterly Interest Expenses of -$4.4 million for Q1 2026, up 56.63% year-over-year from -$2.8 million in Q1 2025, and down 104.9% quarter-over-quarter from $90.7 million in Q4 2025.

Analysis

Cellectis (CLLS) Interest Expenses (2021 - 2026) Analysis & Trends

Cellectis' Interest Expenses history runs 12 years deep, the most recent figure standing at -$4.4 million for Q1 2026.

  • In Q1 2026, Interest Expenses rose 56.63% year-over-year to -$4.4 million; the TTM figure through Mar 2026 stood at $55.7 million (up 1555.4% YoY), while the FY2025 annual figure was $51.1 million, up 136.25% from the prior year.
  • Interest Expenses for Q1 2026 stood at -$4.4 million, down from $90.7 million in the prior quarter.
  • The five-year high for Interest Expenses was $90.7 million in Q4 2025, with the low at -$19.7 million in Q2 2025.
  • The 5-year median for Interest Expenses is -$3.1 million (2024), against an average of $8.2 million.
  • The sharpest annual moves came in 2022 and 2023: Interest Expenses plunged 1134.55% in 2022, then jumped 2221.78% in 2023.
  • Cellectis' Interest Expenses stood at $22.0 million in 2022, then jumped by 190.28% to $63.7 million in 2023, then decreased by 28.35% to $45.7 million in 2024, then jumped by 98.68% to $90.7 million in 2025, then sank by 104.9% to -$4.4 million in 2026.
  • Business Quant data shows CLLS's Interest Expenses at -$4.4 million in Q1 2026, $90.7 million in Q4 2025, and -$10.9 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -1.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 23.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 39.74 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 82.05 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 93.62 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 20.27 Mn
10 Cellectis 321.90 Mn 155.05 Mn - -3.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.01 Mn
Mar 31, 2026 -4.44 Mn
Dec 31, 2025 -11.41 Mn
Sep 30, 2025 -10.91 Mn
Jun 30, 2025 -19.70 Mn
Mar 31, 2025 -10.25 Mn
Dec 31, 2024 2.44 Mn
Sep 30, 2024 -15.41 Mn
Jun 30, 2024 16.65 Mn
Mar 31, 2024 -3.14 Mn
Dec 31, 2023 -17.56 Mn
Sep 30, 2023 -1.62 Mn
Jun 30, 2023 16.28 Mn
Mar 31, 2023 -5.18 Mn
Dec 31, 2022 -13.68 Mn
Sep 30, 2022 -1.09 Mn
Jun 30, 2022 1.69 Mn
Mar 31, 2022 -1.36 Mn
Mar 31, 2021 -1,000.00